Menu
GeneBe

rs114435632

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_014391.3(ANKRD1):c.319G>T(p.Val107Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000423 in 1,612,840 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00022 ( 1 hom. )

Consequence

ANKRD1
NM_014391.3 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.351
Variant links:
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008039564).
BP6
Variant 10-90919157-C-A is Benign according to our data. Variant chr10-90919157-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 45630.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-90919157-C-A is described in Lovd as [Pathogenic]. Variant chr10-90919157-C-A is described in Lovd as [Benign]. Variant chr10-90919157-C-A is described in Lovd as [Likely_benign].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ANKRD1NM_014391.3 linkuse as main transcriptc.319G>T p.Val107Leu missense_variant 3/9 ENST00000371697.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ANKRD1ENST00000371697.4 linkuse as main transcriptc.319G>T p.Val107Leu missense_variant 3/91 NM_014391.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00238
AC:
361
AN:
151542
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00843
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000460
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00241
GnomAD3 exomes
AF:
0.000579
AC:
145
AN:
250616
Hom.:
0
AF XY:
0.000421
AC XY:
57
AN XY:
135454
show subpopulations
Gnomad AFR exome
AF:
0.00834
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000883
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000219
AC:
320
AN:
1461192
Hom.:
1
Cov.:
32
AF XY:
0.000187
AC XY:
136
AN XY:
726880
show subpopulations
Gnomad4 AFR exome
AF:
0.00802
Gnomad4 AMR exome
AF:
0.000291
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000540
Gnomad4 OTH exome
AF:
0.000530
GnomAD4 genome
AF:
0.00239
AC:
362
AN:
151648
Hom.:
1
Cov.:
31
AF XY:
0.00246
AC XY:
182
AN XY:
74128
show subpopulations
Gnomad4 AFR
AF:
0.00843
Gnomad4 AMR
AF:
0.000460
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00238
Alfa
AF:
0.000402
Hom.:
0
Bravo
AF:
0.00255
ESP6500AA
AF:
0.00885
AC:
39
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000717
AC:
87
Asia WGS
AF:
0.000289
AC:
1
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesApr 13, 2021- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 07, 2020This variant is associated with the following publications: (PMID: 23299917, 20981092, 19608030, 19608032, 27143260, 27896284) -
not specified Benign:4
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 21, 2015p.Val107Leu in exon 3 of ANKRD1: This variant is not expected to have clinical s ignificance because it has been identified in 0.8% (81/10346) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs114435632). -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 19, 2023- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteAug 30, 2016- -
Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioFeb 16, 2017- -
ANKRD1-related dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 24, 2024- -
Primary dilated cardiomyopathy Benign:1
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 30, 2018This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.62
Cadd
Benign
10
Dann
Benign
0.63
DEOGEN2
Benign
0.060
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.0080
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.32
N
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.37
N
REVEL
Benign
0.13
Sift
Benign
0.43
T
Sift4G
Benign
0.39
T
Polyphen
0.0
B
Vest4
0.66
MutPred
0.23
Loss of methylation at K108 (P = 0.0386);
MVP
0.65
MPC
0.16
ClinPred
0.00059
T
GERP RS
2.0
Varity_R
0.033
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114435632; hg19: chr10-92678914; API